These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7384962)

  • 1. [Therapy results and clinical course in 91 cases of multiple myeloma with regard to their clinical staging (author's transl)].
    Rubio Felix D; Giraldo MP; Raichs A; García Zueco JC; Mur P; Faura MV; Ruíz-Marcuello E; Piñan MA
    Sangre (Barc); 1980; 25(1):25-34. PubMed ID: 7384962
    [No Abstract]   [Full Text] [Related]  

  • 2. Peptichemio in multiple myeloma. (Preliminary results).
    Cavo M; Gobbi M; Tura S
    Haematologica; 1981 Apr; 66(2):208-15. PubMed ID: 6791997
    [No Abstract]   [Full Text] [Related]  

  • 3. [Multiple myeloma (author's transl)].
    Nakatsuji T; Matsumoto N; Kaku K; Hiroshige Y; Oda S; Shinohara K; Yaga K; Fujii S; Miwa S; Kamei T; Nagasawa T; Tani S
    Rinsho Ketsueki; 1980 Mar; 21(3):347-55. PubMed ID: 7411874
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic factors and survival in multiple myeloma. Analysis of 91 cases treated by melphalan and prednisone.
    Gobbi M; Cavo M; Savelli G; Baccarani M; Tura S
    Haematologica; 1980 Aug; 65(4):437-45. PubMed ID: 6774915
    [No Abstract]   [Full Text] [Related]  

  • 5. [Multiple myeloma transforming into acute leukaemia (author's transl)].
    Mayans J; Redon J; Badia L; Herranz C; Calabuig JR; Sanz MA; Soler A; Caballero M; Marty ML
    Sangre (Barc); 1977; 22(6):1026-9. PubMed ID: 601670
    [No Abstract]   [Full Text] [Related]  

  • 6. [Maintenance therapy with low-dose of melphalan in multiple myeloma (author's transl)].
    Hirasawa Y; Nagaoka T; Kuto F; Tokuhiro H; Kikawada R
    Rinsho Ketsueki; 1980 Nov; 21(11):1646-54. PubMed ID: 7206225
    [No Abstract]   [Full Text] [Related]  

  • 7. [Survival and therapy of multiple myeloma. Apropos of 56 observed cases].
    Locatelli F; Giovanelli E; Neretto G; Furno F; Pellerito R
    Minerva Med; 1979 Mar; 70(13):925-33. PubMed ID: 220567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent progress in chemotherapy of multiple myeloma].
    Tortarolo M; Cantore N; Russolillo S; Castaldo C; Buonanno G
    Recenti Prog Med; 1978 Jul; 65(1):44-68. PubMed ID: 370935
    [No Abstract]   [Full Text] [Related]  

  • 9. Peripheral neuropathy in osteosclerotic myeloma: clinical and electrodiagnostic improvement with chemotherapy.
    Donofrio PD; Albers JW; Greenberg HS; Mitchell BS
    Muscle Nerve; 1984 Feb; 7(2):137-41. PubMed ID: 6325905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple myeloma management.
    Doll DC; Weiss RB
    W V Med J; 1977 Jul; 73(7):151-5. PubMed ID: 267379
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug - resistant multiple myeloma. A trial with the M 2 cyclic alkylating agent polychemotherapy.
    Buonanno G; Tortarolo M; Valente A; Castaldo C; Russolillo S; Gonnella F
    Haematologica; 1978 Feb; 63(1):45-55. PubMed ID: 417971
    [No Abstract]   [Full Text] [Related]  

  • 12. Regression of amyloidosis in multiple myeloma.
    Mehta AD
    Br J Clin Pract; 1978 Dec; 32(12):358-9, 61. PubMed ID: 737115
    [No Abstract]   [Full Text] [Related]  

  • 13. [Multiple myeloma in stage I. Evaluation of the initial therapy].
    Zapatero A; Blanco L; Sevilla F; Escribano L; Odriozola J; Montalbán C
    Rev Clin Esp; 1985 May; 176(8):388-91. PubMed ID: 4023320
    [No Abstract]   [Full Text] [Related]  

  • 14. Melphalan-prednisone versus alternating combination VAD/MP or VND/MP as primary therapy for multiple myeloma: final analysis of a randomized clinical study.
    Cavo M; Benni M; Ronconi S; Fiacchini M; Gozzetti A; Zamagni E; Cellini C; Tosi P; Baccarani M; Tura S;
    Haematologica; 2002 Sep; 87(9):934-42. PubMed ID: 12217805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of plasmacytoma].
    Gassel WD; Sodomann CP
    Ther Ggw; 1980 Sep; 119(9):980-1005. PubMed ID: 7466705
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sideroblastic anemia in a multiple myeloma treated by melphalan (author's transl)].
    Phelip X; Grosclaude S; Rouge P; Mouries D; Blanc D
    Sem Hop; 1979 Oct 18-25; 55(35-36):1633-5. PubMed ID: 231836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple myeloma. II. The value of melphalan.
    Bernard DB; Lynch SR; Bothwell TH; Bezwoda WR; Stevens K; Shulman G
    S Afr Med J; 1974 May; 48(24):1026-8. PubMed ID: 4835772
    [No Abstract]   [Full Text] [Related]  

  • 18. [The treatment of myelomatosis with melphalan (author's transl)].
    Hasegawa M; Aoki M; Ogawa T; Imamura Y; Hino S
    Rinsho Ketsueki; 1977 Aug; 18(8):961-72. PubMed ID: 916219
    [No Abstract]   [Full Text] [Related]  

  • 19. [Extraskeletal manifestations of unusual localization in a case of myeloma (author's transl)].
    Sanz MA; Mayans J; Martínez J; Caballero O; Marty ML
    Med Clin (Barc); 1979 Jul; 73(3):118-21. PubMed ID: 470509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognosis in myelomatosis treated with prednisone and cytostatics].
    Hansen OP; Jessen B; Videbaek A
    Ugeskr Laeger; 1973 Jun; 135(23):1169-73. PubMed ID: 4757116
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.